These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6153836

  • 1. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G, Hansson C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [Abstract] [Full Text] [Related]

  • 2. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
    Ito S, Kato T, Maruta K, Fujita K, Kurahashi T.
    J Chromatogr; 1984 Nov 09; 311(1):154-9. PubMed ID: 6440898
    [No Abstract] [Full Text] [Related]

  • 3. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C, Agrup G, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 Nov 09; 60(2):155-56. PubMed ID: 6155023
    [Abstract] [Full Text] [Related]

  • 4. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1977 Nov 09; 57(4):313-5. PubMed ID: 70922
    [Abstract] [Full Text] [Related]

  • 5. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C, Rorsman H, Rosengren E, Tegner E.
    Acta Derm Venereol; 1981 Nov 09; 61(3):251-5. PubMed ID: 6167110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.
    Romero JA, Lytle LD, Ordonez LA, Wurtman RJ.
    J Pharmacol Exp Ther; 1973 Jan 09; 184(1):67-72. PubMed ID: 4686016
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S, Jimbow K, Kato T, Kiyota M, Fujita K.
    Acta Derm Venereol; 1983 Jan 09; 63(6):463-7. PubMed ID: 6198833
    [Abstract] [Full Text] [Related]

  • 11. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C, Edholm LE, Agrup G, Rorsman H, Rosengren AM, Rosengren E.
    Clin Chim Acta; 1978 Sep 15; 88(3):419-27. PubMed ID: 699334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DOPA in sympathetic nerve tissue--a possible source of serum DOPA in albino animals.
    Hansson C, Poulsen J, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1981 Sep 15; 61(1):69-71. PubMed ID: 6164221
    [Abstract] [Full Text] [Related]

  • 14. Evidence of dopa in the nerves of sea anemones.
    Carlberg M.
    J Neural Transm; 1983 Sep 15; 57(1-2):75-84. PubMed ID: 6137512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE, Hunter JA, Percy-Robb IW, Jay B, Phillips CI, Taylor WO.
    Acta Derm Venereol; 1985 Sep 15; 65(2):169-71. PubMed ID: 2408424
    [Abstract] [Full Text] [Related]

  • 17. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
    Fornstedt B, Bergh I, Rosengren E, Carlsson A.
    J Neurochem; 1990 Feb 15; 54(2):578-86. PubMed ID: 2105377
    [Abstract] [Full Text] [Related]

  • 18. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Feb 15; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 19. [Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)].
    Morishima T, Saito M, Fujita M, Fukada E, Nagashima N, Hanawa S.
    Nihon Hifuka Gakkai Zasshi; 1982 Feb 15; 92(2):157-9. PubMed ID: 6806514
    [No Abstract] [Full Text] [Related]

  • 20. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
    Halldin MM, Cook WS, Kawashima T, Crutcher WA, Fukuyama K.
    Cancer Res; 1987 Jan 15; 47(2):636-8. PubMed ID: 3098416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.